[Role of the vasospastic factor in stenocardia in ischemic heart disease]

Kardiologiia
|February 1, 1982
PubMed

Insights

This study reveals that vasospastic angina pectoris can coexist with other forms, impacting myocardial ischemia localization. Different treatments are effective based on ST-segment changes during angina attacks.

Area of Science:

  • Cardiology
  • Clinical Pharmacology

Background:

  • Coronary artery disease diagnosis and management.
  • Understanding different forms of angina pectoris.

Purpose of the Study:

  • To differentiate vasospastic angina pectoris from other forms.
  • To investigate the localization of myocardial ischemia.
  • To evaluate drug efficacy based on angina presentation.

Main Methods:

  • Selective coronarography in 100 patients.
  • Pharmacological testing with intravenous ergometrine.
  • Myocardial scintigraphy with 201Tl.
  • Echocardiography during anginal attacks.

Main Results:

  • Ergometrine test identifies vasospastic angina, irrespective of coronary lesions or exercise tolerance.
  • Discrepancies in ischemic zone localization between exercise and ergometrine tests suggest dual angina forms.
  • ST-segment elevation during angina shows greater left ventricular dilatation and reduced contractility compared to ST-segment depression.
  • Corinfar effective for ST-segment elevation angina; Inderal ineffective.
  • No difference between Corinfar and Inderal for ST-segment depression angina.

Conclusions:

  • Vasospastic angina pectoris can coexist with other forms, presenting distinct pathogenetic mechanisms and ischemic localization.
  • Echocardiographic findings differ between ST-segment elevation and depression angina.
  • Treatment strategies for angina should consider the specific ECG presentation and underlying mechanisms.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...